DE2817358C2 - - Google Patents

Info

Publication number
DE2817358C2
DE2817358C2 DE2817358A DE2817358A DE2817358C2 DE 2817358 C2 DE2817358 C2 DE 2817358C2 DE 2817358 A DE2817358 A DE 2817358A DE 2817358 A DE2817358 A DE 2817358A DE 2817358 C2 DE2817358 C2 DE 2817358C2
Authority
DE
Germany
Prior art keywords
carnitine
acetyl
formula
heart
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2817358A
Other languages
German (de)
English (en)
Other versions
DE2817358A1 (de
Inventor
Claudio Dr. Rom/Roma It Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT4918077A external-priority patent/IT1126725B/it
Priority claimed from IT4789878A external-priority patent/IT1155813B/it
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE2817358A1 publication Critical patent/DE2817358A1/de
Application granted granted Critical
Publication of DE2817358C2 publication Critical patent/DE2817358C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19782817358 1977-04-29 1978-04-20 Neue therapeutische anwendung von acylderivaten des d,l-carnitin Granted DE2817358A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4918077A IT1126725B (it) 1977-04-29 1977-04-29 Applicazione della acetil-d i-carni tina nella terapia delle affezioni cardiache
IT4789878A IT1155813B (it) 1978-02-03 1978-02-03 Nuova applicazione terapeutica dell'acetil-d i-carnitina e di altri derivati acilati della d- i-carnitina

Publications (2)

Publication Number Publication Date
DE2817358A1 DE2817358A1 (de) 1978-11-02
DE2817358C2 true DE2817358C2 (cg-RX-API-DMAC7.html) 1989-04-27

Family

ID=26329243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782817358 Granted DE2817358A1 (de) 1977-04-29 1978-04-20 Neue therapeutische anwendung von acylderivaten des d,l-carnitin

Country Status (11)

Country Link
US (1) US4194006A (cg-RX-API-DMAC7.html)
JP (1) JPS53136523A (cg-RX-API-DMAC7.html)
AU (1) AU518617B2 (cg-RX-API-DMAC7.html)
BE (1) BE866568A (cg-RX-API-DMAC7.html)
CH (1) CH636268A5 (cg-RX-API-DMAC7.html)
DE (1) DE2817358A1 (cg-RX-API-DMAC7.html)
FR (1) FR2388556A1 (cg-RX-API-DMAC7.html)
GB (1) GB1596491A (cg-RX-API-DMAC7.html)
IE (1) IE46703B1 (cg-RX-API-DMAC7.html)
KE (1) KE3223A (cg-RX-API-DMAC7.html)
NL (1) NL188078C (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2414914A1 (fr) * 1978-01-18 1979-08-17 Sigma Tau Ind Farmaceuti Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156840B (it) * 1978-06-27 1987-02-04 Sigma Tau Ind Farmaceuti Acil derivati della carnitina
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
IT1145362B (it) * 1980-03-06 1986-11-05 Sigma Tau Ind Farmaceuti Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1143214B (it) * 1981-07-09 1986-10-22 Sigma Tau Ind Farmaceuti Acil derivato della carnitina quale immunomodulatore
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
CH676930A5 (cg-RX-API-DMAC7.html) * 1988-05-26 1991-03-28 Bernardini Attilio
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240799B (it) * 1990-03-15 1993-12-17 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1299197B1 (it) * 1998-06-30 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
IT1302125B1 (it) * 1998-08-03 2000-07-31 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
IT1306173B1 (it) * 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
US20040229951A1 (en) * 2003-05-15 2004-11-18 Arthur Vanmoor Method of treating fatigue by enhancing the effectiveness of the human immune system
PT2582368T (pt) 2010-06-16 2018-06-04 Alfasigma Spa Acetil-carnitina, para utilização num método para o aumento da neurogénese em tecido neuronal
IT202100020729A1 (it) 2021-08-02 2023-02-02 Univ Degli Studi Di Napoli Federico Ii Preparazione combinata per il trattamento della malattia di Pompe
CN119033751B (zh) * 2024-09-05 2025-10-31 中国人民解放军海军军医大学 棕榈酰基肉碱在制备预防和/或治疗炎症性肠病的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE719891C (de) * 1938-12-08 1942-04-21 Dr Erich Strack Verfahren zur Herstellung des Methyl- bzw. AEthylesters des acetylierten Carnitins
BE700864A (cg-RX-API-DMAC7.html) * 1967-07-03 1967-12-18
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
JPS531812B2 (cg-RX-API-DMAC7.html) * 1972-12-07 1978-01-23

Also Published As

Publication number Publication date
NL188078C (nl) 1992-04-01
JPH0115483B2 (cg-RX-API-DMAC7.html) 1989-03-17
FR2388556A1 (fr) 1978-11-24
NL7804567A (nl) 1978-10-31
FR2388556B1 (cg-RX-API-DMAC7.html) 1981-05-29
AU518617B2 (en) 1981-10-08
CH636268A5 (it) 1983-05-31
US4194006A (en) 1980-03-18
NL188078B (nl) 1991-11-01
IE780643L (en) 1978-10-29
AU3459878A (en) 1979-10-04
KE3223A (en) 1982-09-03
BE866568A (fr) 1978-08-14
GB1596491A (en) 1981-08-26
JPS53136523A (en) 1978-11-29
DE2817358A1 (de) 1978-11-02
IE46703B1 (en) 1983-08-24

Similar Documents

Publication Publication Date Title
DE2817358C2 (cg-RX-API-DMAC7.html)
DE3015636C2 (de) Pharmazeutische Zubereitung auf der Grundlage von Carnitinestern mit inotroper Wirkung
DE2903579A1 (de) Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
DE69627160T2 (de) Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma-butyrobetain für die behandlung von herz-gefäss-erkrankungen
DE69508551T2 (de) Verwendung von L-Carnitin und Derivaten zur Verringerung der Toxizität von Cyclosporin-A und anderer Immunosuppressiva
DE3686520T2 (de) Verwendung von einigen alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur therapeutischen behandlung von ideopathischem oder induziertem parkinsonismus.
DE1815808B2 (de) 1 -(Alkanoylamiitophenoxy)-3-alkylamino-2-propanole deren Herstellungsverfahren und pharmazeutische Zusammensetzungen auf deren Basis
IE51711B1 (en) Carnitine derivatives
DE3000139A1 (de) Die verwendung von glyzerinphosphorylderivaten in der therapie der dislipaemie, der hepatitis und vergleichgeeignete pharmazeutische kompositionen
DE2846335A1 (de) Derivate des d,l- bzw. l-carnitins sowie diese enthaltende arzneimittel
DE69109721T2 (de) Pharmazeutische Zubereitung mit Wirkung auf das Herzgefässsystem, die 3-Methylthiopropionyl L-Carnitin enthält.
DE3339052A1 (de) Pharmazeutisches praeparat zur verbesserung der biochemischen und verhaltens-parameter bei senilitaet
DE3608726A1 (de) Verwendung aminosubstituierter benzoesaeuren als heilmittel gegen diarrhoe und arzneimittel auf basis dieser verbindungen
DE2029510C3 (de) Dibenzofuranderivate und deren pharmazeutisch verträgliche Säureadditionssalze sowie Verfahren zu deren Herstellung und Arzneimittel mit einem Gehalt dieser Verbindungen
DE3231088C2 (cg-RX-API-DMAC7.html)
DE1963223A1 (de) Mittel zur Behandlung von Virusinfektionen
DE60119336T2 (de) Verwendungen von thaliporphin oder seinen derivaten in der behandlung von herzkrankheiten und seine herstellung
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
DE3043446C2 (cg-RX-API-DMAC7.html)
DE3390386T1 (de) Antitumor-Mittel, Verfahren zur Tumor-Therapie und Verwendung zur Tumor-Therapie
CH678490A5 (cg-RX-API-DMAC7.html)
US3976774A (en) Antiemetic method
AT329551B (de) Verfahren zur herstellung neuer derivate des n-phenyl-n-alkanoyl-2-aminoindans
DE2109657C3 (de) DL-m-Tyrosinester und L-m-Tyrosinester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1518444C (de) erythro alpha Phenyl beta amino propanole, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arz neimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM.

8128 New person/name/address of the agent

Representative=s name: EITLE, W., DIPL.-ING. HOFFMANN, K., DIPL.-ING. DR.

D2 Grant after examination
8364 No opposition during term of opposition